ManagementJon Askaa CEO. Dr. Askaa comes from a position as Director of Companion Diagnostics at Genentech Inc and has been responsible for development and implementation of Companion Diagnostic assays for Genentech's targeted therapy programs. Before that he worked at Dako in Denmark and in California and was responsible for the development and launch of the HercepTest companion diagnostic and several other Companion Diagnostic assays. Phone: +45 26 20 64 45 E-mail: jon.askaa@medical-prognosis.com
Steen Knudsen Founder and CSO. Dr. Knudsen was previously a Professor at the Technical University of Denmark and has authored several books on DNA microarrays. Phone: +45 20 86 52 06 E-mail: steen@medical-prognosis.com |
Announcements
MPI publishes Exercise Response Predictor
MPI, together with... Read more
New CEO as of January 1, 2010.
MPI is proud to announce... Read more Blind clinical validation of drug response predictor
... Read more
|